CoChat

Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis

Open access
Anderson, Sarah A., Barry, John A., Hardiman, Paul J. · 2014 · International Journal of Cardiology
Cited by 77

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Women with polycystic ovary syndrome (PCOS), one of the commonest endocrine conditions in the human, are more likely than other women to have increased blood pressure, endothelial dysfunction, reduced arterial compliance, central obesity, dyslipidaemia, low grade chronic inflammation, and increased endothelin-1 and homocysteine [1]. A recent meta-analysis found an increased incidence of cardiovascular events in women with PCOS, but did not distinguish between coronary heart disease and stroke and did not consider fatal and non-fatal events separately [2]. The present metaanalysis aimed to quantify the risk of non-fatal stroke and coronary heart disease as separate disease events in women with PCOS compared to healthy women. The Mantel–Haenszel method was used, with a random effects model in most cases, to generate an odds ratio (OR) for all included studies combined. Results were considered statistically significant where the probability value was below the 0.05 threshold. Review Manager statistical software, version 5.1, was used to analyse data. Heterogeneity was assessed using I and chi square statistics. Nine studies met the inclusion criteria (see list of included studies here [www.ijc.com/references). Women with PCOS were at increased risk of non-fatal stroke and non-fatal CHD but the odds ratios did not reach statistical significance (OR, 1.61; 95% CI, 0.82–3.15; P = 0.17 and OR, 1.63; 95% CI, 0.96–2.78; P = 0.07, respectively). In the five studies where the average age was more than 45 years old, the risk in PCOS was significantly increased for non-fatal stroke (OR, 1.94; 95% confidence interval, 1.19–3.17) and non-significantly increased in the six studies of CHD (OR, 1.70; 95% confidence interval, 0.92–3.11) (Fig. 1). For the three studies where the BMI was similar and the mean age was over 45 in the groups the risk was non-significantly increased for womenwith PCOS for stroke (OR, 1.67; 95% confidence interval, 0.70– 4.02) and for the three studies of CHD (OR, 2.04; 95% confidence interval, 0.60–6.97). The Newcastle–Ottawa scale suggests that the methodological quality of the included studies was moderate. Funnel plots found that although publication bias cannot be ruled out, the asymmetry observed may be due to the relatively young age of the patients in one study. Women with PCOS appear to be at increased risk of non-fatal stroke and possibly CHD. Although this study was not designed to investigate mechanism, the higher blood pressure and atherogenic lipid profile in women with PCOS may be contributory. In any case, clinicians and policymakers might focus on screening women with PCOS as soon as it is diagnosed, and focus on applying preventative measures, such as lifestyle interventions, appropriate to reducing the risk of stroke. Whilst the results of the present meta-analysis did not provide evidence of increased risk of CVD in PCOS entirely independent of BMI, evidence of cardiovascular risk in leanwomenwith PCOS [3] supports the hypothesis of the potential for an independent role of PCOS in CVD, perhaps due to the abdominal obesity in PCOS [5]. Future studies of PCOS should measure waist circumference in order to assess abdominal obesity. Furthermore, many women with PCOS receive treatments (the oral contraceptive pill, antiandrogens, insulin sensitizers or laparoscopic ovarian diathermy) which are likely to modify the risk of later cardiovascular events [4]. Future studies should therefore also assess the impact of these interventions on cardiovascular risk in women with PCOS. These findings have important implications for disease prevention and screening in women. At present, weight management, changes in dietary composition and exercise should be the primary interventions, although pharmacologic treatment of hypertension, dyslipidaemia or insulin resistancemay be requiredwhere lifestyle modification proves ineffective. No funding supported the preparation of this paper. The authors have nothing to disclose. We would like to thank Dr Richard Morris of University College London for his advice on statistical matters.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijcard.2014.06.079

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 77

Metadata

Authors
Anderson, S. A., Barry, J. A., & Hardiman, P. J.
Venue
International Journal of Cardiology
Publisher
Elsevier BV
Published
2014-09
Volume
176
Issue
2
Pages
486-487
ISSN
0167-5273 (ISSN-L)
OpenAlex
W1981494013
Cited by
77
References
1
FWCI
1.61
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.